SEC ownership of MYRIAD GENETICS INC

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000899923.

Comparable stake leader

BlackRock Portfolio Management LLC

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

31 Aug 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
BlackRock Portfolio Management LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Aug 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000899923
Issuer location
Salt Lake City, UT

Ownership snapshot

Top shareholders of MYRIAD GENETICS INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Portfolio Manag...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Aug 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: BlackRock Portfolio Management LLC Showing 1-8 of 50 holder rows.

Quick read

BlackRock Portfolio Management LLC leads the comparable SEC ownership view at 10%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Portfolio Management LLC's linked filing trail.
Comparable ownership Top 5
BlackRock Portfolio Management LLC 10%
BlackRock, Inc. 8.5%
INTEGRATED CORE STRATEGIES (US) LLC 7.2%
Vestal Point Capital, LP 6.1%
STATE STREET CORP 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Portfolio Management LLC
13D/G
10%
$31,385,970
9,900,937 shares
$0 31 Aug 2026
BlackRock, Inc.
13F 13D/G
Company
8.5%
from 13D/G
$62,184,412
10,890,440 shares
30 Jun 2026
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
Millennium Management LLC
7.2%
$41,205,972
6,700,158 shares
+$12,003,761 31 Dec 2025
Vestal Point Capital, LP
13D/G 13F
Company
6.1%
$33,607,100
5,735,000 shares
$0 30 Jun 2026
STATE STREET CORP
13D/G 13F
STATE STREET CORPORATION · Company
5.3%
$29,212,452
4,985,060 shares
+$3,287,653 30 Jun 2026
BARCLAYS PLC
13D/G 13F
Company
4.2%
$28,480,691
3,939,238 shares
-$6,945,955 30 Sep 2025
Camber Capital Management LP
13D/G
3.4%
$22,320,000
3,100,000 shares
$0 31 Dec 2024
DISCIPLINED GROWTH INVESTORS INC /MN
13D/G
0.8%
$4,244,772
753,956 shares
-$19,924,683 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$655,361.

Buys
$722,204
Insiders: 3
Sells
$66,843
Insiders: 1
Net
+$655,361
Shares: +137,007
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 152,007 Shares: 15,000
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 15,000 $0 $66,843 -$66,843
3-6 47,500 0 $227,482 $0 +$227,482
6-9 104,507 0 $494,722 $0 +$494,722
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 31 reporting-owner rows connected to MYRIAD GENETICS INC. Open a relationship link for the CIK-to-CIK filing trail.

Rows
31
Largest Forms 3/4/5 holder
Paul J. Diaz
Net 12M change
+$655,361
Latest report
16 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Paul J. Diaz President and CEO, Director $13,952,260 Mixed 30 Apr 2025
Richard Bryan Riggsbee Chief Financial Officer $5,585,282 Mixed 29 Jan 2024
Jerry S. Lanchbury Officer $5,059,161 Mixed 14 Jan 2022
Samraat S. Raha President and CEO, Director $4,806,373 +$199,844 +4.3% Mixed 11 Jun 2026
Nicole Lambert Chief Operating Officer $4,287,226 Mixed 31 Oct 2023
Jayne B. Hart Officer $3,302,837 Mixed 01 Mar 2023
Mark Verratti Chief Operating Officer $2,833,595 Mixed 14 Apr 2026
Brian J. Donnelly Chief Commerical Officer $2,580,133 Mixed 11 Jun 2026
Dennis Langer Director $2,044,190 Mixed 30 Jun 2022
S. Louise Phanstiel Director $1,741,115 +$494,722 +40% Mixed 04 Jun 2026
Paul Parkinson Fmr EVP Strategy & Innovation $1,672,970 Mixed 14 May 2021
Benjamin R. Wheeler Chief Financial Officer $1,654,461 Median 16 Aug 2026
Heinrich Dreismann Director $1,598,707 Mixed 03 Jun 2021
Dale Muzzey Chief Scientific Officer $1,468,492 Mixed 14 Apr 2026
Pamela Wong Chief Legal Officer $1,445,644 Mixed 22 Mar 2024
Jennifer Lynne Fox Chief Legal Officer $1,405,939 Mixed 12 Mar 2026
Shereen Solaiman Chief People Officer $1,213,138 Mixed 12 Mar 2026
Scott J. Leffler Chief Financial Officer $1,140,011 Mixed 18 Aug 2025
Raj Jampa Chief Technology Officer $1,133,500 Mixed 01 Jun 2026
Eric Santa Former Chief Growth Officer $1,085,889 Mixed 26 Apr 2022

Recent insider transactions for MYRIAD GENETICS INC

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Benjamin R. Wheeler MYGN Common Stock Tax liability -2.93% -8,761 289,748 16 Aug 2026 Direct
Samraat S. Raha MYGN Common Stock Award 0.33% 3,542 1,068,083 11 Jun 2026 Direct
Brian J. Donnelly MYGN Common Stock Award 0.88% 5,000 573,363 11 Jun 2026 Direct
Rashmi Kumar MYGN Common Stock Sale -8.03% $66,843 $4.46 -15,000 171,889 08 Jun 2026 Direct
Daniel Skovronsky MYGN Common Stock Award 44% 59,701 195,507 04 Jun 2026 Direct
Lee Nisley Newcomer MYGN Common Stock Award 45.2% 59,701 191,842 04 Jun 2026 Direct
Mark S. Davis MYGN Common Stock Award 127.1% 59,701 106,665 04 Jun 2026 Direct
S. Louise Phanstiel MYGN Common Stock Award 21.2% 59,701 341,652 04 Jun 2026 Direct
Heinrich Dreismann MYGN Common Stock Award 34.8% 59,701 231,145 04 Jun 2026 Direct
Colleen F. Reitan MYGN Common Stock Award 64.7% 59,701 152,030 04 Jun 2026 Direct
Paul Bisaro MYGN Common Stock Award 61.3% 59,701 157,142 04 Jun 2026 Direct
Rashmi Kumar MYGN Common Stock Award 46.9% 59,701 186,889 04 Jun 2026 Direct
Raj Jampa MYGN Common Stock Award 251,889 251,889 01 Jun 2026 Direct
Paul Bisaro MYGN Common Stock Purchase 8.34% $27,638 $3.68 7,500 97,441 14 May 2026 Direct
Brian J. Donnelly MYGN Common Stock Tax liability -8.97% -55,975 568,363 01 May 2026 Direct
Mark Verratti MYGN Common Stock Tax liability -0.17% -1,069 629,646 14 Apr 2026 Direct
Dale Muzzey MYGN Common Stock Tax liability -0.29% -946 326,310 14 Apr 2026 Direct
Dale Muzzey MYGN Common Stock Tax liability -0.61% -2,019 327,256 22 Mar 2026 Direct
Mark Verratti MYGN Common Stock Tax liability -0.32% -2,055 630,715 22 Mar 2026 Direct
Benjamin R. Wheeler MYGN Common Stock Tax liability -0.18% -549 298,509 22 Mar 2026 Direct
Kevin Richard Haas MYGN Common Stock Tax liability -6.12% -11,737 180,022 15 Mar 2026 Direct
Dale Muzzey MYGN Common Stock Tax liability -4.84% -16,732 329,275 15 Mar 2026 Direct
Mark Verratti MYGN Common Stock Tax liability -2.27% -14,707 632,770 15 Mar 2026 Direct
Benjamin R. Wheeler MYGN Common Stock Tax liability -1.02% -3,069 299,058 15 Mar 2026 Direct
Kevin Richard Haas MYGN Common Stock Tax liability -2.12% -4,161 191,759 14 Mar 2026 Direct
Shereen Solaiman MYGN Common Stock Tax liability -2.11% -5,784 267,801 14 Mar 2026 Direct
Dale Muzzey MYGN Common Stock Tax liability -2.34% -8,288 346,007 14 Mar 2026 Direct
Mark Verratti MYGN Common Stock Tax liability -0.83% -5,418 647,477 14 Mar 2026 Direct
Benjamin R. Wheeler MYGN Common Stock Tax liability -0.36% -1,097 302,127 14 Mar 2026 Direct
Samraat S. Raha MYGN Common Stock Tax liability -1.01% -10,816 1,064,541 14 Mar 2026 Direct
Kevin Richard Haas MYGN Common Stock Tax liability -3.17% -6,412 195,920 13 Mar 2026 Direct
Shereen Solaiman MYGN Common Stock Tax liability -3.15% -8,899 273,585 13 Mar 2026 Direct
Dale Muzzey MYGN Common Stock Tax liability -3.48% -12,779 354,295 13 Mar 2026 Direct
Jennifer Lynne Fox MYGN Common Stock Tax liability -1.9% -5,995 310,362 13 Mar 2026 Direct
Mark Verratti MYGN Common Stock Tax liability -1.38% -9,164 652,895 13 Mar 2026 Direct
Benjamin R. Wheeler MYGN Common Stock Tax liability -0.19% -586 303,224 13 Mar 2026 Direct
Samraat S. Raha MYGN Common Stock Tax liability -3.27% -36,304 1,075,357 13 Mar 2026 Direct
Shereen Solaiman MYGN Common Stock Award 158.5% 173,196 282,484 12 Mar 2026 Direct
Dale Muzzey MYGN Common Stock Award 89.3% 173,196 367,074 12 Mar 2026 Direct
Jennifer Lynne Fox MYGN Common Stock Award 162.6% 195,876 316,357 12 Mar 2026 Direct
Brian J. Donnelly MYGN Common Stock Award 57% 226,804 624,338 12 Mar 2026 Direct
Mark Verratti MYGN Common Stock Award 59.7% 247,423 662,059 12 Mar 2026 Direct
Benjamin R. Wheeler MYGN Common Stock Award 211.2% 206,186 303,810 12 Mar 2026 Direct
Samraat S. Raha MYGN Common Stock Award 125.4% 618,557 1,111,661 12 Mar 2026 Direct
Samraat S. Raha MYGN Common Stock Purchase 8.83% $199,844 $5.00 40,000 493,104 09 Mar 2026 Direct
Shereen Solaiman MYGN Common Stock Tax liability -1.51% -1,675 109,288 01 Mar 2026 Direct
S. Louise Phanstiel MYGN Common Stock Purchase 20.5% $223,728 $4.66 48,000 281,951 27 Feb 2026 Direct
S. Louise Phanstiel MYGN Common Stock Purchase 27.5% $242,105 $4.80 50,407 233,951 26 Feb 2026 Direct
S. Louise Phanstiel MYGN Common Stock Purchase 3.44% $28,890 $4.74 6,100 183,544 25 Feb 2026 Direct
Benjamin R. Wheeler MYGN Common Stock Award 5.39% 4,994 97,624 02 Feb 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .